NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers
Jul 25, 2017
1 min read
NCI-COG Pediatric Molecular Analysis for Therapy Choice (Pediatric MATCH) is a nationwide trial to explore whether targeted therapies can be effective for children and adolescents with solid tumors that harbor specific genetic mutations and have progressed during or after standard therapy.